PI-LAB-2026-190

Retatrutide, Independent Lab Report

Retatrutide 5mg · Cardinal Metabolic Clinic

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 93.7% met the stated ≥95% claim. Content measured 100.9% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
93.7%

Label claimed ≥95%

Content accuracy
100.8%

5.04mg measured against 5mg claimed

Test recency
Current cycle

Published 5 months ago

Specimen PI-LAB-2026-190 Tested by Chelsea Analytical Group 10 samples tested from this company Purity & Testing score 98/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 95% 93.7% Within analytical tolerance
Identity (MS) Retatrutide Confirmed Matches label
Content 5 mg 5.04 mg Within 5% of label

Methodology & chain of custody

Reversed-phase HPLC purity analysis with UV detection at 214nm.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Chelsea Analytical Group. See our full testing methodology.

Lot / batch
L7275-26
Purchased
Analysed
Published
Laboratory
Chelsea Analytical Group
Test type
Purity & identity

Original laboratory report: PI-LAB-2026-190-report.pdf (document delivery arrives with the production storage backend)

More Tests, Cardinal Metabolic Clinic

Orforglipron
Purity 98.6% Verified
Tirzepatide
Purity 99.2% Verified
Orforglipron
Purity 98.2% Verified

More Tests, Retatrutide

Retatrutide Vector Peptide Supply
Purity 97.6% Verified
Retatrutide NextGen Peptides
Purity 99.7% Verified
Retatrutide Research Peptides Co.
Purity 98.4% Verified